• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Michael Girschikofsky, M. Rita Aricò, +13 authors Kenneth L McClain
  • Medicine, Biology
  • Orphanet Journal of Rare Diseases
  • 2013 (First Publication: 14 May 2013)
  • Langerhans Cell Histiocytosis (LCH) is an orphan disease of clonal dendritic cells which may affect any organ of the body. Most of the knowledge about the diagnosis and therapy is based on pedriaticContinue Reading
  • Peyman Hadji, N. Papaioannou, +9 authors Astrid Fahrleitner-Pammer
  • Medicine
  • Osteoporosis International
  • 2015 (First Publication: 28 May 2015)
  • SummaryPersistence with and adherence to osteoporosis therapy are critical for fracture reduction. This non-interventional study is evaluating medication-taking behavior of women with postmenopausalContinue Reading
  • Maria P. Yavropoulou, Athanasios D. Anastasilakis, Polyzois Makras, Dimitrios G. Tsalikakis, Maria Grammatiki, John Yovos
  • Medicine
  • European journal of endocrinology
  • 2017 (First Publication: 1 February 2017)
  • BACKGROUND Circulating microRNAs (miRs) are currently being investigated as novel biomarkers for osteoporosis and osteoporotic fractures. AIM The aim of this study was to investigate serum levelsContinue Reading
  • Athanasios D. Anastasilakis, Stergios A. Polyzos, Polyzois Makras, Bérengère Aubry-Rozier, Stella Kaouri, Olivier Lamy
  • Medicine
  • Journal of bone and mineral research : the…
  • 2017 (First Publication: 1 June 2017)
  • We aimed to study the clinical and imaging characteristics of patients sustaining vertebral fractures after denosumab discontinuation. For this purpose, we conducted a computerized advancedContinue Reading
  • Athanasios D. Anastasilakis, Konstantinos A. Toulis, Stergios A. Polyzos, Chrysostomos D Anastasilakis, Polyzois Makras
  • Medicine
  • Therapeutics and clinical risk management
  • 2012 (First Publication: 1 June 2012)
  • Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL), a member of the tumor necrosis factor receptor superfamily essential forContinue Reading